CIK 0001533998 · Non-accelerated filer<br>Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452973162
- Phone
- 972-4-770-6377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | Matheis Dennis Director | Grant or award | +70,000 | 152,620 | ||
| 2024-03-06 | STERN ADAM K Director | Grant or award | +70,000 | 194,341 | ||
| 2024-02-15 | STERN ADAM K Director | Grant or award · Series-C Preferred Stock | +250 | $1,000.00 | $250K | 250 |
| 2024-02-15 | Ben-Kiki Tomer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +717,947 | 717,947 | ||
| 2024-02-15 | Ben-Kiki Tomer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2023-05-04 | Matheis Dennis Director | Purchase · Series B-2 Preferred Stock | +50 | $1,000.00 | $50K | 50 |
| 2023-05-04 | Shaked Yoav Director | Purchase · Series B-2 Preferred Stock | +40 | $1,000.00 | $40K | 40 |
| 2023-05-04 | KAPLAN JON H. Director | Purchase · Series B-2 Preferred Stock | +30 | $1,000.00 | $30K | 30 |
| 2023-05-04 | Raphael Erez Chief Executive Officer | Purchase · Series B-2 Preferred Stock | +30 | $1,000.00 | $30K | 30 |
| 2023-01-13 | Raphael Erez Chief Executive Officer | Sale | −1,200 | $6.21 | $7K | 1,112,059 |
| 2022-12-21 | MCGRATH DENNIS M Director | Sale | −9,872 | $3.97 | $39K | 74,744 |
| 2022-06-09 | ANDERSON RICHARD ALAN President, GM of North America | Returned to the company | −17,957 | 108,877 | ||
| 2022-05-18 | Ben-David Zvi Chief Financial Officer | Grant or award | +95,000 | 346,035 | ||
| 2022-05-18 | Shaked Yoav Director | Grant or award | +60,000 | 166,193 | ||
| 2022-05-18 | STONE RICHARD B Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-05-18 | ANDERSON RICHARD ALLAN President, GM of North America | Grant or award · Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2022-05-18 | Karah Hila Director | Grant or award | +80,000 | 149,290 | ||
| 2022-05-18 | Raphael Erez Chief Executive Officer | Grant or award | +275,000 | 1,113,259 | ||
| 2022-05-18 | Bacher Dror Chief Operating Officer | Grant or award | +95,000 | 265,926 | ||
| 2022-05-18 | MCGRATH DENNIS M Director | Grant or award | +55,000 | 84,616 |
Page 4 of 13 · 253 trades